Dental Bone Void Filler Market Size & Growth Forecast 2026–2035, By Segments (Material), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Dental Bone Void Filler Market size was valued at USD 106.01 Million in 2025 and is anticipated to grow at a 6% CAGR from 2026 to 2035, crossing USD 189.85 Million by 2035. The industry revenue for 2026 is calculated at USD 111.55 million.

• Base Year Value (2025): USD 106.01 Million
• CAGR (2026-2035): 6%
• Forecast Year Value (2035): USD 189.85 Million
• Historical Data Period: 2022-2025
• Largest Region: Europe
• Forecast Period: 2026-2035

Dental Bone Void Filler Market Intelligence Snapshot:

• Regional Market Dynamics:

  • Europe leads with a 41.34% share due to a mature dental care ecosystem, widespread implantology adoption, strong periodontal treatment practices, and consistent use of bone regeneration materials in routine clinical and hospital-based settings.
  • Asia Pacific is growing at a 6.78% CAGR, supported by expanding dental infrastructure, rising procedural volumes in urban centers, and increasing adoption of advanced regenerative materials for implant and restorative dental treatments.

• Segment Momentum:

  • DBM is the leading material because its established use in dental grafting, familiar handling characteristics, and broad acceptance in routine bone regeneration procedures continue to support consistent clinical demand.
  • Tricalcium Phosphate Ceramics are growing fastest as providers increasingly adopt standardized synthetic materials with predictable composition, supporting broader use across evolving regenerative dental procedures.

• Market Expansion Drivers:

  • Rising dental implant procedures increasing demand for bone regeneration materials in restorative dentistry.
  • Aging population driving higher incidence of tooth loss and periodontal bone defects globally.
  • Advancements in synthetic biomaterials improving safety and osteoconductivity of dental fillers.

• Leading Market Participants:

  Prominent players in the dental bone void filler market include Medtronic plc (Ireland), Johnson & Johnson (United States), Stryker Corporation (United States), BONESUPPORT AB (Sweden), Curasan AG (Germany), Olympus Terumo Biomaterials Corporation (Japan), Graftys SA (France), Geistlich Pharma AG (Switzerland), Dentsply Sirona Inc. (United States), Zimmer Biomet Holdings, Inc. (United States).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 106.01 Million
  • Projected Market Size: USD 189.85 Million by 2035
  • Growth Forecasts: 6% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: Europe
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Demineralized Bone Matrix (DBM) (Material)
  • Emerging Opportunity Segment: Tricalcium Phosphate Ceramics (Material)

Market Growth Drivers and Industry Trends

Rising dental implant procedures increasing demand for bone regeneration materials in restorative dentistry

As implant dentistry becomes a routine restorative option, clinicians are treating a larger share of patients whose jawbone volume is insufficient for stable implant placement. That directly increases use of graft substitutes and putty-based fillers during socket preservation, ridge augmentation, and peri-implant defect management, making bone regeneration a procedural requirement rather than an occasional adjunct. In the dental bone void filler market, demand is reinforced by the treatment workflow itself: implant success depends on predictable osseous support, so oral surgeons and periodontists are more willing to adopt materials that integrate easily into chairside practice, reduce handling complexity, and support faster case planning for single-tooth replacement and full-arch rehabilitation.

Aging population driving higher incidence of tooth loss and periodontal bone defects globally

An older patient base brings a higher prevalence of edentulism, chronic periodontitis, and alveolar bone resorption, which expands the pool of cases requiring regenerative intervention before or alongside restorative treatment. For the dental bone void filler market, This transitions purchasing toward materials suited for routine management of extraction sockets, infrabony defects, and compromised ridges in patients with slower healing and more complex oral histories. The practical effect is supporting market development through a steadier volume of clinically necessary procedures, particularly in specialist practices where preservation of bone architecture is essential to support dentures, bridges, and implant-based rehabilitation.

Advancements in synthetic biomaterials improving safety and osteoconductivity of dental fillers

Improvements in synthetic calcium phosphate, bioactive glass, and composite formulations are changing clinician preferences by addressing long-standing concerns around variability, disease transmission risk, and inconsistent remodeling associated with some traditional graft sources. In the dental bone void filler market, these advances influence market adoption by making products more predictable in handling, resorption profile, and scaffold performance, which matters in everyday dental surgery where procedural efficiency and outcome consistency drive material selection. As synthetic options become easier to shape, place, and combine with membranes or biologics, they gain traction in practices seeking standardized regenerative protocols and more dependable inventory planning.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising dental implant procedures increasing demand for bone regeneration materials in restorative dentistry	2.40%	High	North America, Europe, Asia Pacific	High	Near Term
Aging population driving higher incidence of tooth loss and periodontal bone defects globally	2.10%	High	North America, Europe, Asia Pacific	High	Mid Term
Advancements in synthetic biomaterials improving safety and osteoconductivity of dental fillers	1.80%	Moderate	Europe, North America	Medium	Long Term

Regional Demand Dynamics

Europe (Largest Region) vs Asia Pacific (Fastest-Growing Region)

Europe held a 41.34% share of the dental bone void filler market in 2025, bolstered by a well-established dental care ecosystem, broad procedural adoption in implantology and periodontal treatment, and consistent use of bone regeneration materials in routine clinical practice. The region’s leadership is reinforced by the presence of experienced dental specialists, mature treatment pathways for tooth loss and jawbone reconstruction, and steady patient access to advanced restorative care, all of which sustain regular demand for bone void filling products across both specialist clinics and hospital-based dental settings.

Asia Pacific is projected to expand at a 6.78% CAGR over the forecast period, with the dental bone void filler market gaining momentum as dental infrastructure improves and access to restorative and implant-related procedures widens across the region. Growth is being impelled by rising procedural volumes in urban dental centers, increasing adoption of advanced dental materials by providers seeking more predictable regenerative outcomes, and a broader shift toward treatment approaches that preserve or rebuild bone structure as part of long-term oral rehabilitation.

Key Country Insights

United States

Advanced Regenerative Adoption

The U.S. dental bone void filler market emphasizes regenerative biomaterials for implantology and periodontal procedures. Dental clinics and specialists in the U.S. increasingly adopt grafting solutions that improve treatment predictability and support minimally invasive clinical workflows.

Japan

Precision Implant Support

Japan continues integrating dental bone void fillers into implant procedures that require precise bone regeneration and consistent healing outcomes. Manufacturers and clinicians in Japan emphasize reliable biomaterials compatible with advanced dental treatment protocols.

South Korea

Cosmetic Dentistry Integration

South Korea incorporates dental bone void fillers into implant and aesthetic dental procedures driven by advanced clinical practices. Dental providers in South Korea increasingly select regenerative materials that shorten treatment timelines and improve functional outcomes.

Germany

Biomaterial Quality Focus

Germany prioritizes clinically validated dental bone void fillers supported by stringent quality standards and advanced manufacturing. Dental professionals in Germany favor products with proven biocompatibility, handling efficiency, and long-term treatment performance.

France

Evidence-Based Applications

France promotes dental bone void fillers with strong clinical evidence across oral surgery and implant dentistry. Healthcare professionals in France focus on material safety, regulatory compliance, and dependable regeneration performance for complex dental procedures.

Italy

Specialist Implant Practice

Italy supports demand for dental bone void fillers through experienced implant specialists and restorative dentistry services. Dental clinics in Italy increasingly evaluate graft materials based on surgical handling, biological compatibility, and successful implant integration.

Segment Leadership and Growth Trends

  Material Segment Analysis: Demineralized Bone Matrix (DBM) (Largest Segment) vs Tricalcium Phosphate Ceramics (Fastest-Growing Segment)

Demineralized Bone Matrix (DBM) held the largest share of the dental bone void filler market in 2025, underpinned by its established use in dental grafting procedures where clinicians value materials that fit well within familiar treatment workflows. its position is underpinned by practical adoption patterns in bone regeneration applications, particularly where handling characteristics and broad procedural acceptance matter in routine dental practice. That continued reliance helps DBM maintain a leading share in the dental bone void filler market.

Tricalcium Phosphate Ceramics is emerging as the fastest-growing material segment in the dental bone void filler market as providers increasingly seek synthetic options that align with evolving procedural preferences and material standardization needs. Its momentum is being encouraged by growing acceptance in cases where predictable composition and expanding use across regenerative dental applications support broader uptake. Compared with traditional alternatives, Tricalcium Phosphate Ceramics is experiencing stronger uptake because it fits the market’s shift toward more controlled and scalable material choices.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Material	Tricalcium Phosphate Ceramics, Biphasic Calcium Phosphate Ceramics, Calcium Phosphate Cements, Calcium Sulfates, Demineralized Bone Matrix (DBM), Others	Demineralized Bone Matrix (DBM)	Tricalcium Phosphate Ceramics

Competitive Landscape and Market Positioning

Leading companies in the dental bone void filler market:

1. Medtronic plc (Ireland)

2. Johnson & Johnson (United States)

3. Stryker Corporation (United States)

4. BONESUPPORT AB (Sweden)

5. Curasan AG (Germany)

6. Olympus Terumo Biomaterials Corporation (Japan)

7. Graftys SA (France)

8. Geistlich Pharma AG (Switzerland)

9. Dentsply Sirona Inc. (United States)

10. Zimmer Biomet Holdings Inc. (United States)

The dental bone void filler market is advancing through continuous improvements in regenerative dental materials and clinical performance. Collaborative initiatives are supporting the development of more effective biomaterial solutions. Ongoing innovation and portfolio expansion activities are strengthening competitiveness across dental restoration applications.

Industry Development/News

Company Name	Date	Key Development
ZimVie Inc.	Apr-23	ZimVie Inc. launched RegenerOssCC Allograft Particulate and RegenerOssBone Graft Plug across the North American region, expanding its dental biomaterials portfolio for bone regeneration applications. The introduction strengthens the company’s position in dental grafting solutions used in restorative and reconstructive procedures.
curasan AG	Jul-22	curasan AG expanded its bone void filler portfolio with CERASORB Calcium Phosphate Cement (CPC) products targeting orthopedic, maxillofacial, and trauma surgery applications. The development enhances its biomaterials offering across surgical bone regeneration use cases.
ZimVie Inc.	Apr-24	ZimVie divested its spine division for USD 375 million, reallocating capital toward dental biomaterials and implant-focused businesses. The strategic restructuring strengthens the company’s focus on dental regeneration and implant-related product categories within its core market.
ZimVie Inc.	Apr-23	ZimVie Inc. launched RegenerOssCC Allograft Particulate and RegenerOss Bone Graft Plug across North America, expanding its dental biomaterials portfolio. The products target bone regeneration applications in dental procedures, strengthening ZimVie’s commercial position in allograft-based regenerative solutions for oral and maxillofacial surgical use.
curasan AG	Jul-22	curasan AG expanded its product portfolio with CERASORB Calcium Phosphate Cement bone void fillers designed for orthopedic, maxillofacial, and trauma surgical applications. The expansion enhances curasan’s presence in synthetic bone graft substitutes and broadens its clinical application scope across multiple surgical segments.
ZimVie Inc.	Apr-24	ZimVie Inc. divested its spine division for USD 375 million and reallocated resources toward dental biomaterials and implant-focused segments. The restructuring strengthens the company’s strategic focus on dental regeneration technologies and supports long-term portfolio concentration within high-growth oral healthcare applications.